Long-Term Anticoagulant Prophylaxis after Myocardial Infarction
- 17 July 1969
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 281 (3) , 115-119
- https://doi.org/10.1056/nejm196907172810301
Abstract
In a double-blind, randomized test, long-term prophylactic anticoagulant therapy after acute myocardial infarction did not reduce mortality rate or complications. More treated patients required hospitalization than patients not receiving anticoagulant drugs. Patients continuously entered the study between 1956 and 1967. The average period at risk was about six years. All patients received six weeks of anticoagulant therapy for initial episodes of infarction, and, time and circumstances permitting, for recurrent myocardial infarctions.Keywords
This publication has 14 references indexed in Scilit:
- A Double Blind Study of Dicumarol Prophylaxis in Coronary Heart DiseaseActa Medica Scandinavica, 2009
- A Double‐blind Trial of Long‐term Anticoagulant Treatment after Myocardial InfarctionActa Medica Scandinavica, 1967
- Prevention of Recurrences of Myocardial InfarctionArchives of internal medicine (1960), 1966
- Prevention of Recurrences of Myocardial InfarctionArchives of internal medicine (1960), 1966
- An Assessment of Long-term Anticoagulant Administration after Cardiac InarctionBMJ, 1964
- Deaths from Coronary Heart Disease in Persons Fifty Years of Age and YoungerNew England Journal of Medicine, 1963
- An overview of anticoagulant therapy for coronary artery diseaseThe American Journal of Medicine, 1962
- Sequential Medical PlansBiometrics, 1952
- INDICATIONS FOR BISHYDROXYCOUMARIN (DICUMAROL®) IN ACUTE MYOCARDIAL INFARCTIONJAMA, 1951
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951